KMC Speciality Hospitals Q1 FY27 results due Aug 14

Board meeting set for August 14, 2026

KMC Speciality Hospitals (India) Ltd has scheduled a board meeting on Friday, 14 August 2026. The company said the meeting will consider and approve the unaudited financial results for the quarter ended 30 June 2026, which corresponds to Q1 FY27. The earnings announcement is also marked as expected on 14/08/2026. For shareholders, the date matters because it sets the next official checkpoint on operating performance after a strong Q4 FY26 profit print.

What the board will consider

The stated agenda is the approval of unaudited quarterly financial results for the quarter ended 30 June 2026. No additional corporate actions were mentioned in the provided information. Companies typically use such meetings to finalise and authorise results for stock exchange disclosures. The update is relevant for market participants tracking quarterly momentum in sales, expenses, and profitability.

Q4 FY26 profit jumped sharply year-on-year

For the quarter ended March 2026 (Q4 FY26), KMC Speciality Hospitals reported profit after tax (PAT) of ₹14.63 crore. The company’s net profit was stated to have jumped 223.67% compared with the same period last year. The data also indicates the Q4 FY26 result continued an upward trend seen across the preceding quarters of FY26. The reported quarterly earnings growth year-on-year figure referenced is 223.67.

Q4 FY26 was also higher sequentially

On a quarter-on-quarter basis, the company’s net profits rose 6.55% versus the previous three-month period, based on the figures provided. PAT increased from ₹13.73 crore in December 2025 (Q3 FY26) to ₹14.63 crore in March 2026 (Q4 FY26). A separate operational disclosure (in lakh terms) aligns with this movement, stating Q4 FY26 PAT at ₹14.6304 crore versus ₹13.7278 crore in Q3 FY26, or about 6.57% QoQ. Basic and diluted EPS for Q4 FY26 was stated at ₹0.90, up from ₹0.84 in Q3 FY26 and ₹0.27 in Q4 FY25.

Revenue and operating metrics for the latest reported quarters

For Q4 FY26, net sales were ₹82.25 crore with total expenditure of ₹56.38 crore, resulting in operating profit of ₹25.87 crore. Other income was ₹1.91 crore, while interest cost was ₹2.03 crore and depreciation was ₹5.95 crore. Profit before tax (PBT) stood at ₹19.80 crore and tax expense at ₹5.17 crore, leading to PAT of ₹14.63 crore. These numbers place the company’s quarterly profitability in context relative to both the cost base and non-operating line items such as other income, interest, and depreciation.

How quarterly performance evolved through FY26

The quarterly table shows a steady rise in revenue and profits from March 2025 through March 2026. Net sales increased from ₹60.94 crore in March 2025 to ₹82.25 crore in March 2026. Over the same span, operating profit rose from ₹15.41 crore to ₹25.87 crore. PAT moved from ₹4.52 crore (March 2025) to ₹14.63 crore (March 2026), indicating a strong profit expansion across the year.

Full-year picture through FY26

The provided FY metric table shows income rising from ₹235 crore in FY25 to ₹311 crore in FY26, while expenses increased from ₹203 crore to ₹248 crore. Net profit was ₹46.73 crore in FY26 versus ₹21.43 crore in FY25. Basic EPS for FY26 was listed at ₹2.87 compared with ₹1.31 in FY25, with diluted EPS also at ₹2.87. The same table reports total comprehensive income of ₹46.10 crore in FY26 compared with ₹20.75 crore in FY25.

Stock and company identifiers mentioned

The information includes the current share price of KMC Speciality Hosp. at ₹123.6. It also references Bombay Stock Exchange Limited and lists the scrip name as “KOVAI”. A phone contact number is shown as 0431-4077777. These are the only trading and contact identifiers provided in the source text.

Market impact: what is known from the numbers

The key market-relevant development is the scheduled results approval date for Q1 FY27, which creates a defined event for investors. Separately, the company’s reported Q4 FY26 profit performance was strong on both a year-on-year basis (223.67% jump stated) and sequential basis (about 6.55% to 6.57% QoQ growth indicated). The revenue line in the quarterly table shows net sales at around ₹82 crore in the latest reported quarter, while the FY table indicates FY26 income at ₹311 crore. However, no forward guidance, capex plans, or management commentary is provided in the text, so the near-term market response would hinge primarily on the upcoming Q1 FY27 numbers once released.

Key numbers at a glance

Conclusion

KMC Speciality Hospitals has set 14 August 2026 as the board meeting date to consider and approve unaudited Q1 FY27 results for the quarter ended 30 June 2026. The timing follows a Q4 FY26 quarter in which PAT was ₹14.63 crore and was reported to be up 223.67% year-on-year, with a sequential increase versus Q3 FY26. The next confirmed milestone is the results approval and disclosure expected on 14/08/2026.